Alexa

FDA Panel Does Not Recommend Removing Chantix Warnings

FDA Review Panel Recommends Leaving Black Box Warnings on Chantix The FDA is set to review evidence submitted by Pfizer in their request to remove serious warnings from their anti-smoking drug, Chantix, which suggest that the drug can trigger depression and suicidal thoughts, among other side effects. However, an FDA review panel has looked at the … [Read more...]

BestLawyers.comAVBetter Business Bureau